Note: Ingredients listed on restricted chemical lists
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
N/A
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
EC/CAS
238-877-9
Name of the chemical
Talc: Hydrated magnesium silicate
Concentration
N/A
General Information
Revision date
2012-04-04
Product name
Norethindrone Acetate Tablets
supplier name
Abbott Laboratories
Emergency telephone
1(800) 424-9300 (in USA and Canada
Icons in SDS
Company Information
company name
Abbott Laboratories
e-mail address of the competent person responsible for the Safety Data Sheet
Abbott.SDS@abbott.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H360
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
2.1 Classification of the substance or mixture
Regulation (EC) No 1272/2008 Reproductive toxicity Category 1B Carcinogenicity Category 2
EU Classification
Directives 67/548/EEC or 1999/45/EC
Hazard statements
R40 - Limited evidence of a carcinogenic effect R60 - May impair fertility R61 - May cause harm to the unborn child H351 - Suspected of causing cancer H360 - May damage fertility or the unborn child
Signal word
Danger
Precautionary statements
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P281 - Use personal protective equipment as required P308 + P313 - IF exposed or concerned: Get medical advice/attention P405 - Store locked up P501 - Dispose of contents/container to an approved waste disposal plant
2.3 Other hazards
Not determined